Chong Kun Dang Pharmaceutical (185750) — Working Capital to Net Assets Ratio
Chong Kun Dang Pharmaceutical (185750) has a Working Capital to Net Assets ratio of 50.8% as of March 2026. Working capital of ₩522.64 Billion (current assets of ₩1.05 Trillion minus current liabilities of ₩522.52 Billion) is measured against net assets of ₩1.03 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Chong Kun Dang Pharmaceutical fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chong Kun Dang Pharmaceutical Working Capital to Net Assets (2016–2025)
This chart shows how Chong Kun Dang Pharmaceutical's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at 50.8%, reflecting working capital of ₩522.64 Billion against net assets of ₩1.03 Trillion KRW. For the complete balance sheet picture, see Chong Kun Dang Pharmaceutical assets under control.
Annual Working Capital to Net Assets for Chong Kun Dang Pharmaceutical (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chong Kun Dang Pharmaceutical from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Chong Kun Dang Pharmaceutical liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 57.2% | ₩575.69 Billion | ₩1.01 Trillion | ₩1.09 Trillion | ₩516.12 Billion | ▼ -9.0 pp |
| 2024 | 66.2% | ₩593.59 Billion | ₩896.38 Billion | ₩962.15 Billion | ₩368.56 Billion | ▲ +12.9 pp |
| 2023 | 53.3% | ₩435.11 Billion | ₩815.64 Billion | ₩946.57 Billion | ₩511.47 Billion | ▼ -1.3 pp |
| 2022 | 54.6% | ₩339.40 Billion | ₩621.29 Billion | ₩713.61 Billion | ₩374.21 Billion | ▼ -6.7 pp |
| 2021 | 61.3% | ₩346.92 Billion | ₩565.81 Billion | ₩667.15 Billion | ₩320.23 Billion | ▲ +10.6 pp |
| 2020 | 50.7% | ₩279.49 Billion | ₩551.59 Billion | ₩600.11 Billion | ₩320.62 Billion | ▲ +9.8 pp |
| 2019 | 40.9% | ₩194.07 Billion | ₩474.95 Billion | ₩471.14 Billion | ₩277.07 Billion | ▼ -2.3 pp |
| 2018 | 43.1% | ₩185.82 Billion | ₩430.90 Billion | ₩390.33 Billion | ₩204.51 Billion | ▲ +7.7 pp |
| 2017 | 35.4% | ₩142.86 Billion | ₩403.29 Billion | ₩366.90 Billion | ₩224.05 Billion | ▼ -0.5 pp |
| 2016 | 35.9% | ₩127.32 Billion | ₩354.25 Billion | ₩338.76 Billion | ₩211.44 Billion | — |